Synergy of flavonoids with HDAC inhibitor: New approach to target Candida tropicalis biofilms

Journal of Chemotherapy

Volumn 27, Issue 4, 2015, Pages 246-249

  Rajasekharan, Satish Kumar ^a   Ramesh, Samiraj ^a   Bakkiyaraj, Dhamodharan ^b  

^a PRIST UNIVERSITY   (India)

^b ALAGAPPA UNIVERSITY   (India)

Author keywords

Antibiofilm; C. tropicalis; Flavonoids; Sodium butyrate

Indexed keywords

BUTYRIC ACID; FLAVONOID; HISTONE DEACETYLASE INHIBITOR; ANTIFUNGAL AGENT;

ANTIFUNGAL ACTIVITY; ARTICLE; BIOFILM; CANDIDA TROPICALIS; FUNGAL STRAIN; FUNGUS GROWTH; LASER MICROSCOPY; MICROBIOLOGY TEST; NONHUMAN; PATHOGENESIS; QUANTITATIVE ASSAY; CANDIDIASIS; DRUG EFFECTS; DRUG POTENTIATION; HUMAN;

ANTIFUNGAL AGENTS; BIOFILMS; CANDIDA TROPICALIS; CANDIDIASIS; DRUG SYNERGISM; FLAVONOIDS; HISTONE DEACETYLASE INHIBITORS; HUMANS;

EID: 84936944430     PISSN: 1120009X     EISSN: 19739478     Source Type: Journal    
DOI: 10.1179/1973947814Y.0000000186     Document Type: Article

References (23)

1. Nucci M, Queiroz-Telles F, Tobon AM, Restrepo A, Colombo AL. Epidemiology of opportunistic fungal infections in Latin America. Clin Infect Dis. 2010; 51: 561e70.
2. Colombo AL, Nucci M, Park BJ, Nouer SA, Arthington-Skaggs B, da Matta DA, et al. For the Brazilian Network Candidemia S. Epidemiology of Candidemia in Brazil: a nationwide sentinel surveillance of Candidemia in eleven medical centers. J Clin Microbiol. 2006; 44(8): 2816-23.
3. Hsueh PR, Graybill JR, Playford EG, Watcharananan SP, Oh MD, Jaalam K, et al. Consensus statement on the management of invasive candidiasis in intensive care units in the Asia-Pacific Region. Int J Antimicrob Agents. 2009; 34(3): 205-9.
4. Álvarez-Lerma F, Nolla-Salas J, Leon C, Palomar M, Jordá R, Carrasco N, et al. Candiduria in critically ill patients admitted to intensive care medical units. Intensive Care Med. 2003; 29(7): 1069-76.
5. Kauffman CA, Vazquez JA, Sobel JD, Gallis HA, McKinsey DS, Karchmer AW, et al. Prospective multicenter surveillance study of funguria in hospitalized patients. Clin Infect Dis. 2000; 30(1): 14-8.
6. Xess I, Jain N, Hasan F, Mandal P, Banerjee U. Epidemiology of candidemia in a tertiary care centre of north India: 5-year study. Infection. 2007; 35(4): 256-9.
7. Douglas LJ. Candida biofilms and their role in infection. Trends Microbiol. 2003; 11: 30-6.
8. Stewart PS, Costerton JW. Antibiotic resistance of bacteria in biofilms. Lancet. 2001; 358: 135.
9. Silva S, Negri M, Henriques M, Oliveira R, Williams DW, Azeredo J. Adherence and biofilm formation of non-Candida albicans Candida species. Trends Microbiol. 2011; 19: 241e7.
10. Bakkiyaraj D, Pandian SK. In vitro and in vivo antibiofilm activity of a coral associated actinomycete against drug resistant Staphylococcus aureus biofilms. Biofouling. 2010; 26: 711-7.
11. Hassig CA, Fleischer TC, Billin AN, Schreiber SL, Ayer DE. Histone deacetylase activity is required for full transcriptional repression by mSin3A. Cell. 1997; 89: 341-7.
12. Nguyen LN, Lopes LCL, Cordero RJB, Nosanchuk JD. Sodium butyrate inhibits pathogenic yeast growth and enhances the functions of macrophages. J Antimicrob Chemother. 2011; 66: 2573-80.
13. Smith WL, Edlind TD. Histone deacetylase inhibitors enhance Candida albicans sensitivity to azoles and related antifungals: correlation with reduction in CDR and ERG up regulation. Antimicrob Agents Chemother. 2002; 46(11): 3532.
14. Al-Dhaheri RS, Douglas LJ. Apoptosis in Candida biofilms exposed to amphotericin B. J Med Microbiol. 2010; 59: 149-57.
15. Jin Y, Yip HK, Samaranayake YH, Yau JY, Samaranayake LP. Biofilm forming ability of Candida albicans is unlikely to contribute to high levels of oral yeast carriage in cases of human immunodeficiency virus infection. J Clin Microbiol. 2003; 41: 2961-7.
16. Silva S, Henriques M, Martins A, Oliveira R, Williams D, Azeredo J. Biofilms of non-Candida albicans Candida species: quantification, structure and matrix composition. Med Mycol. 2009; 47: 681-9.
17. Bakkiyaraj D, Nandhini JR, Malathya B, Pandianan SK. The anti-biofilm potential of pomegranate (Punica granatum L.) Extract against human bacterial and fungal pathogens. Biofouling. 2013; 29: 929-37.
18. Negri M, Silva S, Henriques M, Azeredo J, Svidzinski T, Oliveira R. Candida tropicalis biofilms: artificial urine, urinary catheters and flow model. Med Mycol. 2011; 49: 739-47.
19. Al-Fattani MA, Douglas LJ. Biofilm matrix of Candida albicans and Candida tropicalis: chemical composition and role in drug resistance. J Med Microbiol. 2006; 55: 999-1008.
20. Negri M, Silva S, Breda D, Henriques M, Azeredo J, Oliveira R. Candida tropicalis biofilms: effect on urinary epithelial cells. Microb Pathog. 2012; 53: 95-9.
21. Rajasekharan SK, Ramesh S. Cellulase inhibits Burkholderia cepacia biofilms on diverse prosthetic materials. Pol J Microbiol. 2013; 62: 327.
22. Saito ST, Trentin DS, Macedo AJ, Pungartnik C, Gosmann G, Silveira JD, et al. Bioguided fractionation shows Cassia alata extract to inhibit Staphylococcus epidermidis and Pseudomonas aeruginosa growth and biofilm formation. Evid Based Complement Alternat Med. 2012; 2012: 867103.
23. Lee JH, Park JH, Cho HS, Joo SW, Cho MH, Lee J. Antibiofilm activities of quercetin and tannic acid against Staphylococcus aureus. Biofouling. 2013; 29(5): 491-9.